14.4 C
New York
Wednesday, March 22, 2023

The Question Is Whether To Buy Or Not To Buy Progyny Inc. (NASDAQ: PGNY)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Progyny Inc. (PGNY) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.16, or 0.42%, to $38.39. The Progyny Inc. has recorded 85,538 volume in the after hours trading session.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Stocks Info

Progyny Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Health Information Services industry. At the end of the last regular session, the stock closed at $38.23 and fluctuated between $38.56 as its day high and $36.35 as its day low. The current market capitalization of Progyny Inc. is $3.68B. A total of 1.77 million shares were traded on the day, compared to an average of 1.01M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, PGNY has seen 6 BUY and 20 SELL insider trades, representing the acquisition of 142,149 and the disposition of 212,840 shares. Over the last 12 months, there were 72 BUYs and 294 SELLs from insiders. Insiders purchased 1,821,298 shares during that period but sold 3,031,148.

In the most recent transaction, Payson Norman sold 200 shares of PGNY for 56.29 per share on Nov 23. After the transaction, the Director now owns 580,656 company shares. In a previous transaction on Feb 06, Schlanger David J sold 5,824 shares at 35.26 per share. PGNY shares that Executive Chairman owns now total 76,168.

Among the insiders who sold shares, Anevski Peter disposed of 2,305 shares on Feb 06 at a per-share price of $35.28. This resulted in the CHIEF EXECUTIVE OFFICER holding 223,900 shares of PGNY after the transaction. In another insider transaction, Anevski Peter sold 576 shares at $35.28 per share on Feb 06. Company shares held by the CHIEF EXECUTIVE OFFICER now total 131,838.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for PGNY in the last 3 months, the mean price target is $47.50 with high estimates of $62.00 and low estimates of $34.00. In terms of 52-week highs and lows, PGNY has a high of $53.10 and a low of $25.67.

As of this writing, PGNY has an earnings estimate of $0.01 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $0.03 per share and a lower estimate of -$0.03. The company reported an EPS of $0.09 in the last quarter, which was 125.00% higher than expectations of $0.04.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 6 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PGNY is Overweight with a score of 4.67. A total of 5 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles